VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PGNYProgyny, Inc.
$28.51$2.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPGNYBalance Sheet

Progyny, Inc. (PGNY) Balance Sheet

9Y historyFree accessUpdated daily

The company maintains a healthy liquidity profile with a current ratio of 2.13, though total assets have contracted to $698.3M from $795.2M in 2025Q3.

PGNY Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Total Current Assets501.55M551.77M472.72M640.41M433.86M258.54M190.22M132.44M24.54M16.77M
Cash & Short-Term Investments226.15M310.1M227.95M371.09M189.3M119.42M109.3M80.38M127K4.69M
Cash Only132.65M112.24M162.31M97.3M120.08M91.41M70.31M80.38M127K4.69M
Short-Term Investments93.5M197.86M65.64M273.79M69.22M28M38.99M000
Accounts Receivable263.61M220.29M235.32M241.87M240.07M134.56M75.66M47.06M23.32M11.37M
Days Sales Outstanding71.1562.3973.5981.1111.3598.180.0874.7880.7785.44
Inventory0000000000
Days Inventory Outstanding----------
Other Current Assets11.79M21.39M9.44M27.45M4.49M000200K0
Total Non-Current Assets196.79M190.66M134.38M116.21M109.13M99.53M63.7M17.99M16.79M18.19M
Property, Plant & Equipment59.98M54.92M29.63M27.82M15.27M12.83M12.07M3.08M776K597K
Fixed Asset Turnover24.43x23.47x39.39x39.13x51.52x39.01x28.58x74.50x135.82x81.38x
Goodwill19.88M19.98M15.53M11.88M11.88M11.88M11.88M11.88M11.88M11.88M
Intangible Assets5.97M6.22M1.3M099K599K1.21M2.38M3.86M5.34M
Long-Term Investments925K000000000
Other Non-Current Assets16.95M16.54M2.98M3.4M3.99M2.94M573K652K272K372K
Total Assets698.34M742.43M607.1M756.62M542.99M358.06M253.93M150.43M41.32M34.96M
Asset Turnover1.73x1.74x1.92x1.44x1.45x1.40x1.36x1.53x2.55x1.39x
Asset Growth %47.33%22.29%-19.76%39.34%51.64%41.01%68.8%264.04%18.2%-
Total Current Liabilities235.74M202.39M168.63M185.95M159.54M98.82M77.79M36.16M30.2M17.77M
Accounts Payable157.83M124.07M95.1M125.43M109.29M61.4M43.51M19.39M15.58M5.13M
Days Payables Outstanding50.7246.0137.9853.8764.3857.6957.838.4266.1445.47
Short-Term Debt4.03M0000000253K3.56M
Deferred Revenue (Current)000000009.39M7.13M
Other Current Liabilities73.89M78.32M19.87M13.05M8.88M12.26M7.69M13M11.64M6.73M
Current Ratio2.13x2.73x2.80x3.44x2.72x2.62x2.45x3.66x0.81x0.94x
Quick Ratio2.13x2.73x2.80x3.44x2.72x2.62x2.45x3.66x0.81x0.94x
Cash Conversion Cycle20.43---------
Total Non-Current Liabilities23.25M24M16.41M17.24M6.48M7.42M9.19M0106.24M6.5M
Long-Term Debt0000000001.63M
Capital Lease Obligations97.49M24M16.41M17.24M6.48M7.42M8.32M000
Deferred Tax Liabilities0000000000
Other Non-Current Liabilities000000876K004.87M
Total Liabilities258.99M226.39M185.04M203.19M166.02M106.24M86.98M36.16M30.2M24.27M
Total Debt27.28M24M19.27M19.39M7.71M8.65M9.55M0253K5.19M
Net Debt-105.37M-88.24M-143.04M-77.91M-112.36M-82.76M-60.76M-80.38M126K497K
Debt / Equity0.06x0.05x0.05x0.04x0.02x0.03x0.06x-0.02x0.49x
Debt / EBITDA0.27x0.27x0.27x0.30x0.31x0.26x0.93x---
Net Debt / EBITDA-1.05x-0.98x-2.03x-1.21x-4.51x-2.46x-5.93x-6.81x--
Interest Coverage-------166.84x-6.95x-14.87x
Total Equity439.34M516.04M422.06M553.43M376.97M251.82M166.95M114.27M11.12M10.69M
Equity Growth %57.98%22.27%-23.74%46.81%49.7%50.84%46.1%927.43%4.04%-
Book Value per Share5.185.774.425.503.772.511.691.370.141.88
Total Shareholders' Equity439.34M516.04M422.06M553.43M376.97M251.82M166.95M114.27M11.12M10.69M
Common Stock9K9K9K9K9K9K9K8K1K1K
Retained Earnings227.06M202.83M144.31M89.97M27.93M-2.42M-68.19M-113.48M-104.85M-104.56M
Treasury Stock-505.76M-388.07M-303.89M-1.01M-1.01M-1.01M-1.01M-1.01M-884K0
Accumulated OCI277K498K39K2.82M501K-93K1K-150.43M-483K-83K
Minority Interest0000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Enterprise client concentration risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Balance Sheet Contraction Amidst Headwinds

As reported in recent financial filings, Progyny's total assets declined from $795.2M in 2025Q3 to $698.3M in 2026Q1, signaling a contractionary trend that aligns with the company's recent loss of major enterprise clients and a more conservative approach to capital management in a maturing market.

The reduction in total assets appears to reflect a combination of aggressive share repurchases and a cooling of the growth trajectory that previously fueled rapid balance sheet expansion. Investors should monitor whether this shrinkage is a temporary adjustment to client churn or a structural shift toward a smaller, more capital-efficient operating footprint.

Liquidity Buffer Remains Sufficiently Robust

Based on the latest quarterly data, Progyny maintains a current ratio of 2.13, which, while down from the 3.44 peak observed in 2023Q4, continues to provide a comfortable buffer against short-term operational shocks and potential volatility in medical claims settlement timing.

The company's liquidity position appears adequate to cover its current liabilities, even as cash reserves fluctuate due to capital deployment activities. This liquidity profile suggests the firm is well-positioned to navigate near-term operational uncertainty without requiring external financing, provided that utilization rates remain within expected actuarial bounds.

Equity Quality Impacted by Repurchases

According to financial statements, equity has decreased from a peak of $571.6M in 2024Q1 to $439.3M in 2026Q1, a trend largely driven by the company's recent decision to prioritize significant share repurchases over the retention of earnings on the balance sheet.

While the reduction in equity may improve return on equity metrics, it also reduces the total capital cushion available to absorb potential future losses or regulatory-driven operational disruptions. Analysts should evaluate whether this capital allocation strategy is sustainable if revenue growth continues to face headwinds from enterprise client churn.

Hidden Risks in Asset Composition

As evidenced by the balance sheet, the company's reliance on a lean asset base with minimal PPE, currently at $60.0M, suggests that the firm's true value is tied to intangible client relationships rather than physical infrastructure, which may be vulnerable to rapid erosion.

The lack of significant tangible assets implies that the company's valuation is highly sensitive to the retention of its core enterprise client base. If the recent loss of a major client signals a broader trend, the current asset valuation may be subject to impairment risks that are not immediately apparent in the headline figures.

PGNY — Frequently Asked Questions

Quick answers to the most common questions about buying PGNY stock.

What are the total assets of Progyny, Inc. (PGNY)?

As of 2025, Progyny, Inc. (PGNY) had total assets of $742.4M including $551.8M in current assets.

How much debt does Progyny, Inc. (PGNY) have?

Progyny, Inc. (PGNY) carries total debt of $24.0M, offset by $310.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Progyny, Inc.?

Progyny, Inc. (PGNY) has total shareholders' equity (book value) of $516.0M ($5.77 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Progyny, Inc.'s current ratio and liquidity?

Progyny, Inc. (PGNY) reported a current ratio of 2.73x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.